"GSK pumps up to $800m for US manufacturing site upgrade" was originally created and published by Pharmaceutical Technology, ...

GSK has made another investment in its manufacturing network, setting aside $800 million to build two plants at its Marietta site in the US. The programme represents the largest capital spend by ...

GSK said the vast majority of the products will be for export to global markets, adding that the investment builds on the company’s existing network of nine UK manufacturing sites, employing ...

Sanofi unveiled a plan to build a $1 billion manufacturing site in Beijing while completing construction at a plant in Singapore. GSK inked an antibody-drug conjugate deal with DualityBio and ...

SINGAPORE - The expansion of British drugmaker GSK’s facility in Tuas has earned ... an affiliate of German biotech company BioNTech acquired a manufacturing site from Novartis Singapore to ...

Working out of 12 manufacturing sites, the company distributed 767 million vaccine doses across more than 160 countries in 2021. More than ten million people received one of GSK’s meningococcal ...